Formulary and Prescribing Guidelines
Medicines Management
Please click on the heading to view formulary, shared care guidelines and pathways for each BNF chapter.
Coronavirus (COVID-19) - Patients
COVID 19 AstraZeneca vaccination guide
Patient information - how to help your pharmacy
Frequently asked questions - ordering medicines when self isolating
How patients can order repeat prescriptions electronically
Problems with Sharing of Medicines
Frequently asked questions - Inhalers and Coronavirus
FAQ for patients on immunosuppressants
Palliative care patient information leaflet
Rheumatology advice letter - shielding, self-isolation or maintaining social distancing
Coronavirus (COVID-19) - Clinicians
Vitamin D in Care Homes
Guidance for Care Homes on the use of Vitamin D supplements obtained by the DHSC
Coronavirus Position Statement
Position statement for prescribing for patients abroad during Coronavirus outbreak
Prescription management during COVID-19
Useful Covid-19 Resources
Information around medicines use in Covid-19 is changing rapidly. Stay on top of the most recent information produced by the government and the Royal Pharmaceutical Society, using the links below:
https://www.rpharms.com/coronavirus
https://www.nice.org.uk/covid-19
https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-19
Please note that only registered users can download the below documents:
Covid-19 Vaccine
COVID-19 primary care vaccine handling and management policy
Covid-19 Vaccine Pharmacy Communications Reference Guide
Letter from Chief Medical Officers re UK Covid-19 Vaccination Programme
Optimising the Covid-19 vaccination programme for maximum short term impact
Patient Group Direction for COVID-19 Vaccines
Standard operating procedure: COVID-19 local vaccination services deployment in community settings
Pfizer
Specialist Pharmacy Service (SPS) Covid-19 Pfizer-BioNTech vaccine resources
Patient Group Direction for COVID 19 mRNA vaccine BNT162b2 (Pfizer BioNTech)
National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)
Referrals for cohort 6 16 and 17 year olds who require a Pfizer vaccination
AstraZeneca
Specialist Pharmacy Service (SPS) - Resources for AstraZeneca Covid-19 vaccine
Patient Group Direction for COVID-19 Vaccine AstraZeneca
National protocol for COVID-19 Vaccine AstraZeneca
Position Statement AstraZeneca Vaccine Movement
Transporting AstraZeneca COVID-19 Vaccine from PCN Designated Sites to end user locations SOP
Moderna
Moderna Covid 19 Vaccine Protocol
Covid-19 and professional advice
Security advice for pharmacies during COVID 19
COVID related professional advice
NHS Volunteer Responders information for health professionals
Covid-19 and services
Remote Outpatient Clinics - Medicines Supply
Responsibility for Prescribing - May 2020
Monitoring of shared care medicines during the COVID 19 pandemic
Access to Palliative Care Drugs for clinicans
Access to EOL Drugs in Primary Care during Covid-19
MSE Hospitals Group Anticoagulation Clinics
Covid-19 and medicines
Ibuprofen and coronavirus (COVID 19)
Rescue packs for COPD and asthma for clinicians
Ramadan summary fasting recommendations - British Islamic Medical Association
Chapter 01 - Gastro-Intestinal System
Chapter 02 - Cardiovascular System
Chapter 03 - Respiratory System
Chapter 04 - Central Nervous System
Central nervous system formulary
Cannabis products MSEMOC position statement
Chronic Fatigue Syndrome (CFS) or myalgic encephalomyelitis (ME)
Chronic migraine - pathway for PbR excluded drugs for preventing chronic migraine in adults
Co-Proxamol is not supported for acute or chronic pain
EPUT formulary and shared care guidelines
Fentanyl immediate release preparations MSEMOC position statement
Good practice for Paracetamol prescribing
Low dose naltrexone for the treatment of Multiple Sclerosis
Melatonin (Slenyto®) for the treatment of insomnia
Melatonin for children and adolescents
Oxycodone naloxone MSEMOC position statement
Chapter 05 - Infection
Chapter 06 - Endocrine System
Chapter 07 - Genito-Urinary System
Chapter 08 - Malignant Disease
Chapter 09 - Nutrition and Blood
Oral Nutritional Supplements Guidelines
Adult Oral Nutritional Supplements Prescribing Guidelines
Quick reference guide to ONS prescribing in adults
Supporting Leaflets for Cows' Milk Allergy
COLOUR Cows' Milk Allergy leaflet for families - 2018
BLACK + WHITE Cows' Milk Allergy leaflet for families - 2018
Dairy free diet information for breastfeeding mothers
Primary Care Milk Allergy Pathway
Secondary Care Milk Allergy Pathway
Infant Formula Guidelines (IFG)
Infant formula prescribing guidelines
Quick reference guide to prescribing infant formula
Vitamin and Mineral Guidelines
Ferric maltol (Feraccru®) for the treatment of iron deficiency in adults
Vitamin D deficiency prescribing guidance
Vitamin D for supplementation insufficiency and maintenance doses MSEMOC position statement
Vitamin D - guidance for care homes on the use of Vitamin D supplements obtained by the DHSC
Stopping low dose vitamin D patient letter
Multivitamins post-bariatric surgery MSEMOC position statement
Multivitamins not supported unless for actual vitamin/mineral deficiency
Gluten-free Prescription Guidelines
Gluten-free foods on prescription
Thickeners for Adults with Dysphagia
Chapter 10 - Musculoskeletal System
Chapter 11 - Eye
Chapter 12 - Ear, Nose and Oropharynx
Chapter 13 - Skin
Eflornithine (Vaniqa®) cream MSEMOC position statement
Emollients prescribing guidance
Emollients for dry skin patient letter
Emollients switch to an alternative patient letter
Brimonidine tartrate MSEMOC position statement
Camouflage creams MSEMOC position statement
Fungal nail infections topical treatments MSEMOC position statement
Potassium hydroxide 5% (Molludab, Mollutrex) solution MSEMOC position statement
Pigmanorm cream for the treatment of melasma
Chapter 14 – Immunological Products and Vaccines
General Prescribing Guidance
End of Life Formulary
Woundcare Formulary
Traffic Light List for Prescribing
Shared Care Guidelines
Mid and South Essex Medicines Optimisation Committee (MSEMOC)
Prescribing Incentive Scheme
Prescribing Updates / Newsletters
Patient Information
Over the Counter medicines leaflets
Over the counter patient info sheet
Easy read over the counter leaflet
Braltus Zonda Frequently Asked Questions
Changes to Co-Proxamol Prescribing
Changes to Dosulepin Prescribing
Changes to Doxazosin Prescribing
Changes to Glucosamine Prescribing
Changes to Herbal Treatment Prescribing
Changes to Homeopathy Prescribing
Changes to Immediate Release Fentanyl Prescribing
Changes to Lidocaine Plaster Prescribing
Changes to liothyronine prescribing
Changes to Lutein and Antioxidant supplements Prescribing
Changes to Omega 3 Fatty Acids Prescribing
Changes to Once Daily Tadalafil Prescribing
Changes to Perindopril Arginine Prescribing
Changes to Rubefacients Prescribing
Changes to TarginactA Prescribing
Changes to TramacetA Prescribing
Changes to Travel Vaccines Prescribing
Changes to Trimipramine Prescribing
Patient Letters
Practice Resources/Policies
Electronic Prescription Service (EPS)
Electronic Repeat Dispensing (eRD)
Guide for Designated Medical Practitioners
Instructions for Requests for Prescribing Code or Changes to practices
Management and control of prescription forms
Reauthorisation of B12 Injections
What products or interventions are available to aid medication adherence
Eclipse
National Medicine Shortages
Please note that only registered users can download the below documents:
April 2021
Supply issues update for primary and secondary care - April 2021
January 2021
Supply issues update for primary and secondary care - January 2021
Supply Shortages - January 2021
December 2020
Supply Shortages - December 2020